These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15547788)

  • 21. [Opipramol in anxiety and somatoform disorders. Results of a controlled study].
    Volz HP; Möller HJ
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S21-4. PubMed ID: 9922923
    [No Abstract]   [Full Text] [Related]  

  • 22. HIF-1alpha contributes to tumour-selective killing by the sigma receptor antagonist rimcazole.
    Achison M; Boylan MT; Hupp TR; Spruce BA
    Oncogene; 2007 Feb; 26(8):1137-46. PubMed ID: 16924239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. sigma-1 receptors in major depression and anxiety.
    Kulkarni SK; Dhir A
    Expert Rev Neurother; 2009 Jul; 9(7):1021-34. PubMed ID: 19589051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of the antidepressive properties of opipramol, imipramine and placebo in neurotic depression].
    Tétreault L; Doucet P; Blanchet A; Bordeleau JM
    Union Med Can; 1966 May; 95(5):546-53. PubMed ID: 5326793
    [No Abstract]   [Full Text] [Related]  

  • 25. Opipramol and trifluoperazine in the treatment of anxiety and tension.
    Barritt JM; McGuinness BW; Beaumont G
    J R Coll Gen Pract; 1969 Jun; 17(83):395-400. PubMed ID: 4891824
    [No Abstract]   [Full Text] [Related]  

  • 26. Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity.
    Mésangeau C; Narayanan S; Green AM; Shaikh J; Kaushal N; Viard E; Xu YT; Fishback JA; Poupaert JH; Matsumoto RR; McCurdy CR
    J Med Chem; 2008 Mar; 51(5):1482-6. PubMed ID: 18278854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A; Kulkarni SK
    Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain.
    Cobos EJ; Baeyens JM; Del Pozo E
    Synapse; 2005 Mar; 55(3):192-5. PubMed ID: 15635593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent sigma ligands.
    Costantino L; Gandolfi F; Sorbi C; Franchini S; Prezzavento O; Vittorio F; Ronsisvalle G; Leonardi A; Poggesi E; Brasili L
    J Med Chem; 2005 Jan; 48(1):266-73. PubMed ID: 15634021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opipramol and chlordiazepoxide in the treatment of anxiety in general practice.
    Murphy JE; Beaumont G; Donald JF
    Practitioner; 1970 Nov; 205(229):677-83. PubMed ID: 4923895
    [No Abstract]   [Full Text] [Related]  

  • 31. The sigma ligand JO 1784 prevents trimethyltin-induced behavioural and sigma-receptor dysfunction in the rat.
    O'Connell AW; Earley B; Leonard BE
    Pharmacol Toxicol; 1996 May; 78(5):296-302. PubMed ID: 8737963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity of sigma-receptor ligands is associated with major changes of cellular metabolism and complete occupancy of the sigma-2 subpopulation.
    Rybczynska AA; Dierckx RA; Ishiwata K; Elsinga PH; van Waarde A
    J Nucl Med; 2008 Dec; 49(12):2049-56. PubMed ID: 18997057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial.
    Volz HP; Möller HJ; Reimann I; Stoll KD
    Eur Neuropsychopharmacol; 2000 May; 10(3):211-7. PubMed ID: 10793324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation.
    Tchedre KT; Yorio T
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2577-88. PubMed ID: 18296662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral pharmacology of sigma-ligands.
    Skuza G; Wedzony K
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S183-8. PubMed ID: 15547784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential antidepressant activity of sigma ligands.
    Skuza G
    Pol J Pharmacol; 2003; 55(6):923-34. PubMed ID: 14730086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Opipramol (Insidon) in the treatment of somatoform disorders].
    Freyberger HJ; Grabe HJ; Maier W; Janca A; Stoll KD
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S25-30. PubMed ID: 9922924
    [No Abstract]   [Full Text] [Related]  

  • 38. Thiophene bioisosteres of spirocyclic sigma receptor ligands. 1. N-substituted spiro[piperidine-4,4'-thieno[3,2-c]pyrans].
    Oberdorf C; Schepmann D; Vela JM; Diaz JL; Holenz J; Wünsch B
    J Med Chem; 2008 Oct; 51(20):6531-7. PubMed ID: 18816044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel sigma receptor ligands: synthesis and biological profile.
    Prezzavento O; Campisi A; Ronsisvalle S; Li Volti G; Marrazzo A; Bramanti V; Cannavò G; Vanella L; Cagnotto A; Mennini T; Ientile R; Ronsisvalle G
    J Med Chem; 2007 Mar; 50(5):951-61. PubMed ID: 17328523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
    Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
    Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.